EN DE
Watch Leef Brands Inc. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Leef Brands Inc. (LEEEF) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Leef Brands Inc. stock $0.19, price $0.17, upside +13.1%, quality 39 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Home Canada · ISIN CA52426X2032

LB Leef Brands Inc. logo Thin data Nov 10, 2026

Leef Brands Inc.

LEEEF · US
Fairly valued, weak quality

The stock costs 12% less than our calculation considers fair.

Fair value $0.1929 · Fairly valued
Expensive Growth (revenue 5y +42.4 %/yr in USD)
Negative equity (buybacks among others)
Mixed vs. peers (3/7)
Quality 39/100
Loss-making · -52.7% net margin (TTM) · excl. goodwill write-downs -46.0%
Negative free cash flow
Narrow moat 21/100 · thin data
Thin data
Estimate
Watch Leef Brands Inc. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$3.26 $0.0525 Fair Value $0.1929 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range $0.0525 – $3.26 · fair‑value band $0.1447 – $0.2411 · the $0.1706 price screens below the $0.1929 fair value. As of Nov 10, 2026.

Follow Leef Brands in your weekly email

Every Wednesday you see whether Leef Brands is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Leef Brands Inc. operates as a cannabis branded products manufacturer in the United States. The company operates through two segments: Wholesale Concentrates and Retail.

Show moreShow less

It is involved in the propagation, nursery, flowering canopy, drying, processing, manufacturing, and distribution of cannabis concentrates; and owns and operates retail cannabis store.

The company was formerly known as Icanic Brands Company Inc. and changed its name to Leef Brands Inc. in December 2022. Leef Brands Inc. is headquartered in Vancouver, Canada.

Stock analysis

Leef Brands Inc. (LEEEF) currently trades at $0.1706, while our estimate is $0.1929, so the stock looks roughly fairly valued today (gap 11.6%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $0.1447 (bear) to $0.2411 (bull), the price of $0.1706 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Leef Brands Inc. reported revenue of $34.8M in FY2025 versus $7.9M in FY2021, a compound +45.1%/yr. Reported net income was −$17.6M in FY2025.

Key figures

Market cap $44.0M Micro · P/S ratio 1.41 · EPS (TTM) $−0.1000 · Net margin −52.7% · Return on equity −506% · Return on assets (EBIT) −15.0% (5-year average) · Operating margin 13.7% · Revenue (TTM) $34.8M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 21 out of 100 (low confidence).

What moves the price

The share trades about 23% below its 52-week high and 58% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 13%, LEEEF screens cheaper than that median.

Fair Value

Bear $0.1447 Fair Value $0.1929 Bull $0.2411
Price $0.1706 · Upside +13.1%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 39/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 31
How much profit the company makes from its sales and capital
Quality Growth 93
Are margins and returns getting better?
Cashflow 5
Do the profits arrive as real cash?
Financial strength 7
Debt, balance sheet and risk of trouble
Investment 98
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 29
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 37
Distance to the 52-week high, does not count
New shares 50
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 44/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+22.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+42.4%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+173.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−56.6% (2020) → −15.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch LEEEF, get fair value alerts →

Compare Leef Brands Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 606 stocks

Beats the industry median on 3/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 39 · Bottom 25%
Fair Value upside +13.1% · Above median
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −48.4% · Bottom 25%
Net margin (12 months) −52.7% · Bottom 25%
Operating margin (12 months) 13.7% · Above median
Growth and dividend
Revenue growth (quarter YoY) −0.2% · Below median
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 1.27× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)51 · sector 18
FUTURE (revenue growth)0 · sector 25
PAST (return on equity)0 · sector 25
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 31

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Zoetis Inc ZTS $82.46 $113.53 +38% vs LEEEF
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥48.55 ¥55.21 +14% vs LEEEF
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,905 ₹1,983 +4% vs LEEEF
Haleon plc HLN $9.06 $8.62 −5% vs LEEEF
Merck KGaA MRK €149.35 €109.18 −27% vs LEEEF
Galderma Group GALD CHF 188.55 CHF 109.80 −42% vs LEEEF
Takeda Pharmaceutical Company TAK $20.93 $11.34 −46% vs LEEEF
Teva Pharmaceutical Industries Limited TEVA $42.40 $20.74 −51% vs LEEEF
Sandoz Group SDZ CHF 83.38 CHF 39.70 −52% vs LEEEF
Divi's Laboratories Limited DIVISLAB ₹11,566 ₹1,567 −86% vs LEEEF

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Leef Brands Inc.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Leef Brands Inc. Fair Value". https://www.fairvalue-calculator.com/stock/LEEEF

Frequently asked questions

Is Leef Brands Inc. (LEEEF) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $0.1929 versus a price of $0.1706, about +13% upside (fairly valued).
What is the fair value of LEEEF?
Our estimate for Leef Brands Inc. is $0.1929 (as of Nov 10, 2026), built from audited fundamentals. The current price: $0.1706.
What is the quality score of LEEEF?
Leef Brands Inc. has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Leef Brands Inc. (LEEEF)?
Our calculated price target is the estimate of $0.1929 (as of Nov 10, 2026). Cautious scenario $0.1447, optimistic scenario $0.2411. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Leef Brands Inc. stock forecast for 2026?
Our estimate puts fair value at $0.1929, about +13% upside versus a price of $0.1706 (fairly valued). Cautious scenario $0.1447, optimistic scenario $0.2411. The calculation is refreshed regularly with new filings.
What is the revenue of Leef Brands Inc. (LEEEF)?
Leef Brands Inc. reported trailing-twelve-month revenue of about $34.8M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Leef Brands Inc. (LEEEF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Leef Brands Inc. it is $0.1929 per share (as of Nov 10, 2026), against a price of $0.1706.
Is Leef Brands Inc. stock overvalued or undervalued in 2026?
As of Nov 10, 2026, LEEEF trades below its calculated fair value: price $0.1706, fair value $0.1929, a gap of about +13% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LEEEF?
No. The price is what the market pays today ($0.1706); the fair value is what the company's own numbers justify ($0.1929). For Leef Brands Inc. the two are $0.0223 per share apart. That gap is exactly why we show both numbers side by side.
How much is Leef Brands Inc. worth?
The market values Leef Brands Inc. at about $44.0M (market capitalisation, as of Nov 10, 2026). Per share that is $0.1706; our models calculate a fair value of $0.1929 per share.
What do the bullish and bearish scenarios say about LEEEF?
Our models span a range for Leef Brands Inc.: cautious scenario $0.1447, base $0.1929, optimistic $0.2411 per share (as of Nov 10, 2026, price $0.1706). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Leef Brands Inc. (LEEEF)?
Balance-sheet figures for Leef Brands Inc. (as of Nov 10, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 39/100, which measures business quality independently of the share price.
How far is LEEEF from its 52-week high?
Leef Brands Inc. trades at $0.1706, about 23% below its 52-week high of $0.2220 and 58% above the low of $0.1080 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of $0.1929 is for.
Which stocks are comparable to Leef Brands Inc.?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Galderma Group, Teva Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Leef Brands Inc. stock attractive at the current price?
The data as of Nov 10, 2026: price $0.1706, calculated fair value $0.1929 (+13%), Quality Score 39/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Leef Brands Inc. currently trades 12% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Leef Brands Inc. (LEEEF)?
The closing price on Nov 10, 2026 was $0.1706. Our estimate is $0.1929, about +13% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Leef Brands Inc. right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Leef Brands Inc.

How large is the market capitalisation of Leef Brands Inc. (LEEEF)?
The market capitalisation of Leef Brands Inc. is $44.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Leef Brands Inc. (LEEEF)?
The price-to-sales ratio of Leef Brands Inc. is 1.41 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Leef Brands Inc. (LEEEF)?
Earnings per share at Leef Brands Inc. are $−0.1000. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Leef Brands Inc. (LEEEF)?
The net margin of Leef Brands Inc. is −52.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Leef Brands Inc. (LEEEF)?
The return on equity (ROE) of Leef Brands Inc. is −506% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Leef Brands Inc. (LEEEF)?
On an EBIT basis the return on assets of Leef Brands Inc. is −15.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Leef Brands Inc. (LEEEF)?
The operating margin of Leef Brands Inc. is 13.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Leef Brands Inc. (LEEEF)?
Revenue at Leef Brands Inc. is growing −0.2% versus a year earlier (3y avg +8.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Leef Brands Inc. (LEEEF) generate?
The free cash flow of Leef Brands Inc. is −$1.5M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Leef Brands Inc. (LEEEF) carry?
The net debt of Leef Brands Inc. is $8.6M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Leef Brands Inc. in the live analysis

One click puts Leef Brands Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.